GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Traditional Chinese Medicine Holdings Co Ltd (HKSE:00570) » Definitions » Valuation Rank

China Traditional Chinese Medicine Holdings Co (HKSE:00570) Valuation Rank


View and export this data going back to 1993. Start your Free Trial

What is China Traditional Chinese Medicine Holdings Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


China Traditional Chinese Medicine Holdings Co Valuation Rank Related Terms

Thank you for viewing the detailed overview of China Traditional Chinese Medicine Holdings Co's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


China Traditional Chinese Medicine Holdings Co (HKSE:00570) Business Description

Traded in Other Exchanges
Address
288 Hennessy Road, Room 1601, Emperor Group Centre, Wanchai, Hong Kong, HKG
China Traditional Chinese Medicine Holdings Co Ltd is engaged in the Chinese healthcare sector. The company functions through five segments, finished drugs; concentrated TCM granules; TCM decoction pieces; TCM healthcare complex, and Local TCM integrated operation. It generates maximum revenue from the concentrated TCM granules segment. Geographically, it derives a majority of its revenue from Mainland China.